Experimental CAR-T therapy targets Hard-to-Treat myeloma
Disease control
Recruiting now
This early-stage trial is testing a new type of CAR-T cell therapy made from donated umbilical cord blood. The cells are designed to attack two targets (BCMA and CD19) on myeloma cancer cells. Up to 18 adults with relapsed or refractory multiple myeloma will receive the treatment…
Phase: PHASE1 • Sponsor: Xi'an No.3 Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC